-+ 0.00%
-+ 0.00%
-+ 0.00%

IOVANCE ANNOUNCES DATA SHOWING DURABLE RESPONSES WITH LIFILEUCEL TIL CELL THERAPY IN ADVANCED SOFT TISSUE SARCOMAS AT ESMO 2026

Reuters·10/26/2026 11:03:07